Pure solutions Official (1) method Sensor 1 Sensor 2 Sensor 3
Taken (mg)   Recovery (%) R.S.D.% Recovery (%) R.S.D.% Recovery (%) R.S.D.%
4.74   99.21 1.11 98.84 0.53 99.18 0.27
7.11 99.53 0.85 98.75 0.38 99.25 0.33
14.20 99.00 0.97 98.55 0.47 99.78 0.78
X ± S.E. 98.5 ± 0.5 99.25 ± 0.05 98.71 ± 0.12 99.40 ± 0.09
F value   1.85 2.05 1.45
t value 2.74 2.93 1.89
Praxilene (200 mg)
4.74   99.85 0.76 98.23 0.87 100.58 0.54
7.11   100.54 0.25 98.66 1.05 101.89 0.93
14.20   101.25 0.35 98.47 1.25 101.25 0.36
X ± S.E. 101.7 ± 0.5 100.55 ± 0.05 98.45 ± 0.52 101.24 ± 0.14
F value   2.51 1.81 1.37
t value   1.39 1.55 0.76
Spiked Plasma
X ± S.E.   101.95 ± 0.50 101.70 ± 0.35 101.20 ± 0.15
F value 0.84 1.23 0.44
t value 0.73 1.09 0.39
Spiked Urine
X ± S.E.   101.50 ± 0.25 101.65 ± 0.42 101.25 ± 0.33
F value 1.36 1.68 1.34
t value 0.68 1.74 1.53
X ± S.E: Recovery ± standard error F- tabulated is 6.39 at 95.0% confidence limit, t-tabulated at 99.0% confidence limit and 6 degrees of freedom (1) British Pharmacopoeia (Non-aqueous titration with 0.1 M perchloric acid)
Table 6: Determination of Nf-CMCPs applying the standard addition method in bulk powder, Praxilene (200 mg) and spiked human plasma/urine and its statistical data treatments in comparison with official methods.